SGN-LIV1A

· Seagen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGN-LIV1A, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer [Phase 1, Phase 2]

See pricing